India's pharmaceutical industry: Global supply chain and governance in the post-COVID-19 world

Raghbendra Jha and Ashok Sharma

ASARC Working Papers from The Australian National University, Australia South Asia Research Centre

Abstract: COVID-19 has halted the world with significant impacts on human lives and economies. Humanity is facing the biggest challenge since the Second World War. As the world grapples with this pandemic, questions are also being raised about China’s role in the COVID-19 outbreak. The issues that are being debated include the current model of the supply chain and the need to diversify from China, global governance, and crisis management in the Post-COVID-19 world. In this context, this paper examines the significant role that India’s pharmaceutical industry can play to establish India’s rightful place among nations providing global leadership in the Post-COVID-19 world.

Keywords: COVID-19 pandemic; pharmaceuticals; PPE; China; India; global supply chain; global governance (search for similar items in EconPapers)
JEL-codes: I15 I18 L60 L65 (search for similar items in EconPapers)
Pages: 29
Date: 2020
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://acde.crawford.anu.edu.au/sites/default/fil ... _governance34437.pdf (application/pdf)
Our link check indicates that this URL is bad, the error code is: 404 Not Found

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pas:asarcc:2020-01

Access Statistics for this paper

More papers in ASARC Working Papers from The Australian National University, Australia South Asia Research Centre Contact information at EDIRC.
Bibliographic data for series maintained by Raghbendra Jha ( this e-mail address is bad, please contact ).